Methanol extract of Solanum violaceum root possesess antiobesity, hypolipidemic, thrombolytic and membrane stabilizing activity

Year 2018, Volume: 22 Issue: 1, 96 - 102, 27.06.2025

Sayed Koushik Ahamed Md. Imdadul Huque Khan Md. Mustahsan Billah Mohammad Salim Hossain

Abstract

Roots of Solanum violaceum (S. violaceum) is used traditionally in different therapeutic applications in Bangladesh. Root extract of S. violaceum was investigated for total phenolic content (TPC), antiobesity, anti-hyperlipidemic, membrane stability and thrombolytic activity. Total phenolic content (TPC) was determined using folin-ciocalteu method. High fat diet induced obese mice were used for anti obesity and antihyperlipidemic test. Body weight gain, blood total cholesterol, triglyceride level were analyzed. Thrombolytic and membrane stability activity were evaluated by using human erythrocytes. Total phenolic content in root extract of S. violaceum was calculated as 51.26 mg gallic acid equivalent GAE/g of dry weight. The extractive supplementation with dose of 200mg/ kg and 400mg/kg were capable of lowering the level of triglyceride and total cholesterol significantly (p<0.05) in high fat diet (HFD) induced obese mice in a dose dependent manner. As a membrane stabilizing agent, crude extract was able to inhibit the erythrocyte heamolysis significantly (p< 0.05) with a value of 28.02±5.09% and 32.97± 4.12% respectively for heat and hypotonic solution induced condition. Moreover, 21.56 ±2.62 % of clot lysis was exhibited by the extract for its thrombolytic activity. The root of S. violaceum justifies its potential as anti obese agent. Further research is recommended to find out the active metabolites from this source.

Keywords

obesity , antihyperlipidemia , thrombolysis , inflammation , s. violaceum

References

• [1] Ghani A. Medicinal Plants of Bangladesh: Chemical Constituents and Uses. Asiatic Society of Bangladesh, Dhaka, Bangladesh, 1998.
• [2] Babu PD, Subhasree RS. Antimicrobial activities of Lawsonia inermis: A review. Acad J Plant Sci. 2009;2:231-232.
• [3] Sujatha S. Complementary and alternative therapies in palliative care: A transition from modern medicine to traditional medicine in India. J Cancer Pain Sym Pall. 2005;1:25-29.
• [4] Khan MA, Marwat KB, Gul B, Wahid F, Khan H, Hashim S. Pistia stratiotes (Araceae): phytochemistry, use in medicines, phytoremediation, biogas and management options. Pak J Bot. 2014;46(3):851-860.
• [5] Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11-25.
• [6] Jong WY. Possible anti-obesity therapeutics from nature – A review. Phytochemistry. 2010;71:1625-1641.
• [7] Chowdhury JA, Islam MS, Asifuzzaman SK, Islam MK. Antibacterial and cytotoxic activity screening of leaf extracts of Vitex negundo (Fam: Verbenaceae). J Pharm Sci Res. 2009;1:103-108.
• [8] Pennachio M, Jefferson L, Havens K. Uses and Abuses of Plant-Derived Smoke: Its Ethnobotany as Hallucinogen, Perfume, Incense, and Medicine. Oxford University Press, New York, USA, 2010.
• [9] Jain SK, Borthakur SK. Solanaceae in Indian tradition, folklore, and medicine. In: D’Arcy WG, Solanaceae: Biology and Systematics, Columbia University Press, New York, 1986.
• [10] Ezeugwu CO, Okonta JM, Nwodo NJ. Antidiabetic properties of ethanolic fruit extract of Solanum aethiopicum L. Res J Pharmaceut Allied Sci. 2004;2(2):251-254.
• [11] Anosike CA, Abonyi O, Ubaka CM. Does the African garden egg offer protection against experimentally induced ulcers? Asian Pac J Trop Med. 2011;4(2):163-166.
• [12] Buettner R, lmerich JS, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity. 2007;15(4):798-808.
• [13] Gajda AM. High fat diets for diet-induced obesity models. Open Diet Purified Formula for Rats. 2009.
• [14] Anon. Pravastatin, simvastatin, and lovastatin for lowering serum cholesterol concentrations. Med Lett Drugs Ther. 1992;34:57-58.
• [15] Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: unexplored potential. Drug Discov Today. 2007;12:879-889.
• [16] Ballinger A, Peikin SR. Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol. 2002;440:109-117.
• [17] Han LK, Takaku T, Li J, Kimura Y, Okuda H. Anti-obesity action of oolong tea. Int J Obes Relat Metab Disord. 1999;23:98-105.
• [18] Lin JK, Lin-Shiau SY. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res. 2006;50:211-218.
• [19] Nakai M, Fukui Y, Asami S, Toyoda-Ono Y, Iwashita T, Shibata H, Mitsunaga T, Hashimoto F, Kiso Y. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J Agric Food Chem. 2005;53(11):4593-4598.
• [20] Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome – a review. Phytochemistry. 2009;70:11-24.
• [21] Hwang JT, Park IJ, Shin JI, Lee YK, Baik HW, Ha J, Park OJ. Ganistein, ECGC, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun. 2005;338(2):694-699.
• [22] Lin J, Della-Fera MA, Baile CA. Green tea polyphenol epigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1 adipocytes. Obes Res. 2005;13(6):982-990.
• [23] Hsu CL, Yen GC. Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Mol Nutr Food Res. 2008;52(1):53-61.
• [24] Raju GS, Moghal MMR, Dewan SMR, Amin MN, Billah MM. Characterization of phytoconstituents and evaluation of total phenolic content, anthelmintic, and antimicrobial activities of Solanum violaceum Ortega. Avicenna J Phytomed. 2013;3(4):313-320.
• [25] Stein PD, Beemath A, Olson RE. Obesity as a risk factor in venous thromboembolism. Am J Med. 2005;118(9):978-980.
• [26] Nicolini FA, Nichols WW, Mehta JL, Saldeen TGP, Schofield R, Ross M, Player DW, Pohl GB, Mattsson C. Sustained reflow in dogs with coronary thrombosis with K2P, a novel mutant of tissue plasminogen activator. J Am Coll Cardiol. 1992;20(1):228-235.
• [27] Marder VJ. Recombinant streptokinase – opportunity for an improved agent. Blood Coagul Fibrinolysis. 1993;4:1039-1040.
• [28] Wu DH, Shi GY, Chuang WJ, Hsu JM, Young KC, Chang CW, Wu HL. Coiled coil region of streptokinase gamma-domain is essential for plasminogen activation. J Biol Chem. 2001;276(18):15025-15033.
• [29] Hossain MS, Chowdhury AA, Rahman MS, Nishimura K, Jisaka M, Nagaya T, Shono F, Yokota K. Development of enzyme-linked immunosorbent assay for D12-prostaglandin J2 and its application to the measurement of the endogenous product generated by cultured adipocytes during the maturation phase. Prostaglandins Other Lipid Mediat. 2011;94:73-80.
• [30] Shinde UA, Phadke AS, Nair AM, Mungantiwar AA, Dikshit VJ, Saraf MN. Membrane stabilizing activity – a possible mechanism of action for the anti-inflammatory activity of Cedrus deodara wood oil. Fitoterapia. 1989;70:251-257.
• [31] Omale J, Okafor PN. Comparative antioxidant capacity, membrane stabilization, polyphenol composition and cytotoxicity of the leaf and stem of Cissus multistriata. Afr J Biotechnol. 2008;7:3129-3133.
• [32] Anosike CA, Obidoa O, Ezeanyika LUS. Membrane stabilization as a mechanism of the anti-inflammatory activity of methanol extract of garden egg (Solanum aethiopicum). Daru J Pharm Sci. 2012;20(1):76.
• [33] Singleton VL, Rossi JA. Colorimetry of total phenolic with phosphomolybdic-phosphotungstic acid reagent. Am J Enol Viticult. 1965;16:144-158.
• [34] Kim DO, Jeong SW, Lee CY. Antioxidant capacity of phenolic phytochemicals from various cultivars of plums. Food Chem. 2003;81:321-326.
• [35] Allian CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-475.
• [36] Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476-482.
• [37] Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complement Alternat Med. 2007;7:36.